Lingering Risk of COVID Variants and Adverse Effects of COPD Increasing Need for Innovative Medical Ventilators

Rockville, MD , Dec. 18, 2024 (GLOBE NEWSWIRE) -- The global Medical Ventilator Market is estimated at US$ 1.9 billion in 2024 and is foreseen to increase at a CAGR of 9.9% during the next 10 years (2024 to 2034), estimates Fact.MR, a market research and competitive intelligence provider, in its recently updated research report.

Rising cases of chronic respiratory disorders and a surge in the cases of COVID-19 mutations across the world are creating lucrative opportunities for medical ventilator suppliers. Chronic obstructive pulmonary disease (COPD) is one of the major disorders hampering the health of many individuals. Most of these patients require air respiratory devices to combat the adverse effects of COPD. 

• According to the World Health Organization, in low- and middle-income economies, approximately 90% of COPD patients under the age of 70 pass away. 
  

Ups and downs in cases related to corona variants are expected to drive the need for medical ventilators in healthcare settings across the world. Technological advancements, advent of advanced portable breathing technologies, and clearance of the latest medical ventilators will boost the profits of manufacturers. Strategic moves by companies to consolidate their market position through the acquisition of new or small companies and collaborations with other players are expected to be highly observed over the coming years. 

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4727

Key Takeaways from Market Study:

• The global medical ventilator market is calculated to reach US$ 4.8 billion by 2034.
• The United States is expected to account for 44.5% of the North American market share in 2024.
• Demand for medical ventilators in Japan is forecasted to rise at a CAGR of 10.4% in the coming 10 years.
• Non-invasive medical ventilator demand is anticipated at a market value of US$ 1 billion in 2024.
• Transport and portable medical ventilator sales are projected to reach US$ 2.2 billion by 2034.
  

“Integration of advanced technologies such as smart sensors, artificial intelligence, and the Internet of Robotics is leading to the development of sophisticated medical ventilators,” says a Fact.MR analyst. 

Leading Players Driving Innovation in the Medical Ventilator Market:

Becton Dickinson and Company; Smiths Group Plc.; Getinge AB; Cardinal Health Inc.; GE Healthcare; Drägerwerk AG & Co. KGaA; Leistung Equipamentos LTDA; Koninklijke Philips N.V; Hamilton Medical AG; Smith Medical Inc.; Air Liquide; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Fisher & Paykel Healthcare; Bunnell Incorporated.

Non-invasive Ventilation Systems Effective in Managing Breathing Emergences in Healthcare Settings:

Non-invasive ventilators have emerged as lifesaving respiratory devices for amyotrophic lateral sclerosis (ALS) patients. Non-invasive neonatal ventilators are also finding high application in the treatment of tuberculosis patients. Cost-effectiveness, effective results, and positive delivery of oxygen are contributing to the increasing popularity of non-invasive ventilators.

• On March 15, 2024, Vapotherm, Inc. declared the launch of its Access365™ Home Ventilation Solution. This technology is expected to emerge as an effective respiratory solution for patients with late-stage hypercapnic chronic obstructive pulmonary disease (COPD).
  

Medical Ventilator Industry News:

• In July 2023, Getinge received a clearance from the United States Food and Drug Administration (US FDA) for Servo-air® Lite. It is a wall gas, independent non-invasive mechanical ventilator.
  
• Philips Healthcare developed the Trilogy EV300 ventilator that delivers enhanced performance in non-invasive (NIV) and invasive (IV) ventilation. As such, patients can be treated with a single device throughout their hospital stay, regardless of changing conditions.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=4727

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the global medical ventilator market, presenting historical demand data (2019 to 2023) and forecast statistics for the period (2024 to 2034).

The study divulges essential insights on the market based on product type (critical care medical ventilators, transport & portable medical ventilators, neonatal medical ventilators), technology (invasive medical ventilators, non-invasive medical ventilators), and end user (hospitals, ambulatory surgical centers, long-term care centers, home care settings, emergency health services), across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).

Explore More Related Studies Published by Fact.MR Research: 

 The neonatal ventilator market reached a valuation of US$ 387.05 Million by 2021, and is likely to register a Y-o-Y growth rate of 6.0% in 2022, closing at US$ 413.37 Million. Furthermore, across the 2023-2033 period of assessment, growth is expected to accelerate at a whopping 6.8% CAGR, reaching US$ 798.1 Million.

Non-invasive Ventilator Market Analysis by Electric, Pneumatic, and Elecro-Pneumatic for Hospitals, Specialty Clinics, Home Care Settings, and Ambulatory Surgical Centers from 2023 to 2033

The global heat recovery ventilator market is estimated at a value of US$ 5.89 billion in 2024, according to the updated report published by Fact.MR. Revenue from the sales of heat recovery ventilators (HRVs) is forecast to climb at a CAGR of 3.8% and reach US$ 8.56 billion by the end of 2034.

The global home menopause testing market is approximated to generate revenue worth US$ 18.1 billion in 2024 and has been thoroughly analyzed to increase at 7.1% CAGR to achieve a size of US$ 36.06 billion by 2034-end.

The global pharmaceuticals & medicine manufacturing market is estimated to reach a valuation of US$ 1,073.08 billion in 2024 and further expand at a CAGR of 8.9% to end up at US$ 2,516.46 billion by the year 2034.

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.